The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GlycoMimetics Inc shares valued at $10,188 were sold by Invus Public Equities, L.P. on Aug 06 ’24. At $0.18 per share, Invus Public Equities, L.P. sold 55,732 shares. The insider’s holdings dropped to 6,639,926 shares worth approximately $1.26 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Invus Public Equities, L.P. sold 164,523 shares, netting a total of over 30,996 in proceeds. Following the sale of shares at $0.19 each, the insider now holds 6,695,658 shares.
Before that, Invus Public Equities, L.P. had sold 286,200 shares from its account. In a trade valued at $57,354, the 10% Owner traded GlycoMimetics Inc shares for $0.20 each. Upon closing the transaction, the insider’s holdings decreased to 286,200 shares, worth approximately $1.3 million.
As published in a research note from TD Cowen on July 26, 2024, GlycoMimetics Inc [GLYC] has been rated down from a Buy to a Hold. Analysts at CapitalOne started covering the stock with ‘”an Overweight”‘ outlook in a report released in late December. As of November 12, 2021, Jefferies has increased its “Hold” rating to a “Buy” for GLYC. Earlier on November 14, 2019, ROTH Capital initiated its rating. Their recommendation was “a Buy” for GLYC stock.
Analyzing GLYC Stock Performance
During the last five days, there has been a drop of approximately -13.15%. Over the course of the year, GlycoMimetics Inc shares have dropped approximately -92.05%. Shares of the company reached a 52-week high of $3.5299 on 01/23/24 and a 52-week low of $0.1711 on 08/07/24. A 50-day SMA is recorded $0.2644, while a 200-day SMA reached $1.6625. Nevertheless, trading volume fell to 1.64 million shares from 1.07 million shares the previous day.
Support And Resistance Levels for GlycoMimetics Inc (GLYC)
According to the 24-hour chart, there is a support level at 0.1764, which, if violated, would cause prices to drop to 0.1652. In the upper region, resistance lies at 0.1984. The next price resistance is at 0.2092. RSI (Relative Strength Index) is 32.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0504, which suggests the price will decrease in the coming days. Percent R is at 89.62%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
